Accelerated Transcranial Magnetic Stimulation (aTMS) protocols have emerged as a new approach to reducing treatment duration while maintaining clinical effectiveness for patients with Major Depressive Disorder (MDD).
As interest in accelerated treatment delivery continues to grow, clinicians are seeking practical guidance on protocol selection and implementation.
Join us to hear from Dr. Andrew F. Leuchter, Distinguished Professor of Psychiatry and Director of the Neuromodulation Division at UCLA. An internationally recognized expert in mood disorders and neuromodulation, Dr. Leuchter directs UCLA’s Transcranial Magnetic Stimulation (TMS) Clinical and Research Service, one of the largest academic TMS programs in the United States.
In this webinar, Dr. Leuchter will cover:
- An overview of the recently published 5 × 5 accelerated rTMS study and its implications for clinical practice.
- Clinical outcomes and key findings comparing accelerated and conventional TMS protocols.
- Practical considerations for implementing accelerated TMS protocols in a clinical setting.
Tuesday Jul 14, 2026 · 09:00 Pacific Time (US and Canada)
Can’t attend at this time? Please register to receive the recording.
Clearance: The MagVenture Accelerated TMS Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode (k260189).
Disclaimer: This content is intended for health care and research-based professionals. Slides or fragmented information should not be shared or taken out of context. Regulatory approvals for MagVenture TMS systems and coils may vary by country. Approved indications are subject to local regulatory guidelines. Please consult your regional authority to confirm approved use and ensure this information is relevant to you. To read more about our approvals visit our website www.magventure.com. MagVenture devices are only for sale by or on the order of a physician or research professional.